Advancing Corticosteroids And Hormonal Therapies For Supply And Scale

In this episode of Beyond Biotech, we explored the fascinating world of corticosteroids and hormonal therapies—essential active pharmaceutical ingredients (APIs) that play a vital role in treating conditions ranging from asthma and autoimmune diseases to diabetes and endocrine disorders. While many of these molecules have been used for decades, their development and manufacturing remained among the most complex and critical processes in the pharmaceutical industry.

Our guest was Olivier Roux, Senior Director at Curia. During the conversation, Olivier discussed how Curia collaborated with both emerging biotech companies and global pharmaceutical leaders to navigate the unique challenges of steroid APIs, strengthen supply chain resilience, and prepare for the next generation of therapies. He also shared valuable insights into what it takes to bring these life-changing medicines from concept to patient. The discussion offered a compelling look at the science, manufacturing expertise, and innovation behind therapies that impact millions of lives worldwide.